Effects of the lipid environment, cholesterol and bile acids on the function of the purified and reconstituted human ABCG2 protein (Q39233676)

10 September 2017

Effects of the lipid environment, cholesterol and bile acids on the function of the purified and reconstituted human ABCG2 protein (English)

1 reference

10 September 2017

Ágnes Telbisz

1

1 reference

10 September 2017

Csilla Özvegy-Laczka

2

1 reference

10 September 2017

Tamás Hegedűs

3

1 reference

10 September 2017

András Váradi

4

1 reference

10 September 2017

Balázs Sarkadi

5

1 reference

10 September 2017

language of work or name

English

0 references

publication date

1 March 2013

1 reference

10 September 2017

1 reference

10 September 2017

450

1 reference

10 September 2017

2

1 reference

10 September 2017

387-395

1 reference

Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system

10 September 2017

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121485

ABC transporters: unvalidated therapeutic targets in cancer and the CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121485

Recombinant synthesis of human ABCG2 expressed in the yeast Saccharomyces cerevisiae: an experimental methodological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121485

Purification and 3D structural analysis of oligomeric human multidrug transporter ABCG2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121485

Purification of breast cancer resistance protein ABCG2 and role of arginine-482.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121485

Cholesterol potentiates ABCG2 activity in a heterologous expression system: improved in vitro model to study function of human ABCG2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121485

Localization of the human breast cancer resistance protein (BCRP/ABCG2) in lipid rafts/caveolae and modulation of its activity by cholesterol in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121485

Membrane cholesterol selectively modulates the activity of the human ABCG2 multidrug transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121485

Characterization of drug transport, ATP hydrolysis, and nucleotide trapping by the human ABCG2 multidrug transporter. Modulation of substrate specificity by a point mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121485

Functional characterization of the human multidrug transporter, ABCG2, expressed in insect cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121485

Interaction with the 5D3 monoclonal antibody is regulated by intramolecular rearrangements but not by covalent dimer formation of the human ABCG2 multidrug transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121485

Single amino acid (482) variants of the ABCG2 multidrug transporter: major differences in transport capacity and substrate recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121485

Effects of lipids on ATPase activity of purified Chinese hamster P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121485

Dominant-negative inhibition of breast cancer resistance protein as drug efflux pump through the inhibition of S-S dependent homodimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121485

Interaction of nilotinib, dasatinib and bosutinib with ABCB1 and ABCG2: implications for altered anti-cancer effects and pharmacological properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121485

Role reversal for anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121485

Function-dependent conformational changes of the ABCG2 multidrug transporter modify its interaction with a monoclonal antibody on the cell surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121485

The nature of amino acid 482 of human ABCG2 affects substrate transport and ATP hydrolysis but not substrate binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121485

Antibody binding shift assay for rapid screening of drug interactions with the human ABCG2 multidrug transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121485

Optimized purification of a heterodimeric ABC transporter in a highly stable form amenable to 2-D crystallization

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121485

Purification and reconstitution of the antigen transport complex TAP: a prerequisite for determination of peptide stoichiometry and ATP hydrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121485

Partial purification and reconstitution of the human multidrug-resistance pump: characterization of the drug-stimulatable ATP hydrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121485

The ABC transporter structure and mechanism: perspectives on recent research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121485

Structure and mechanism of ABC transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121485

Mitoxantrone is expelled by the ABCG2 multidrug transporter directly from the plasma membrane.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121485

Characterization of the role of ABCG2 as a bile acid transporter in liver and placenta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121485

P-glycoprotein in proteoliposomes with low residual detergent: the effects of cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121485

The effects of lipids and detergents on ATPase-active P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121485

The reconstituted P-glycoprotein multidrug transporter is a flippase for glucosylceramide and other simple glycosphingolipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121485

Interaction of the P-glycoprotein multidrug efflux pump with cholesterol: effects on ATPase activity, drug binding and transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121485

The multidrug transporter, P-glycoprotein, actively mediates cholesterol redistribution in the cell membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121485

Cholesterol-mediated activation of P-glycoprotein: distinct effects on basal and drug-induced ATPase activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121485

The importance of cholesterol in maintenance of P-glycoprotein activity and its membrane perturbing influence

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121485

Tyrosine kinase inhibitor resistance in cancer: role of ABC multidrug transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121485

Transition State Analysis of the Coupling of Drug Transport to ATP Hydrolysis by P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121485

Multidrug efflux pumps: substrate selection in ATP-binding cassette multidrug efflux pumps--first come, first served?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121485

21 January 2018

Identifiers

DOI

10.1042/BJ20121485

1 reference

release_fauhl6u43zfnpivvhnw6f6utx4

10 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fauhl6u43zfnpivvhnw6f6utx4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference